Durvalumab Consolidation After Definitive Chemoradiotherapy in Patients with Unresectable Stage III Non-Small Cell Lung Cancer: A Real-World Cohort Analysis from the German Prospective, Observational CRISP Registry (AIO-TRK-0315)

10. August 2026

Stuschke M, Thomas M, Gröschel A, Sebastian M, Reck M, Hoffknecht P, Grah C, Spring L, Jänicke M, Lennartz C, Ludwig P, Groth A, Sadjadian P, Christopoulos P, Christoph DC, Griesinger F, Passlick B, Eberhardt WEE, on behalf of the CRISP Registry Group.

Cancers. 2026; 18(14):2316.

Abstract